View in EDS HTML Full Text PDF Full Text

The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment

Saved in:
Bibliographic Details
Title: The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment
Authors: Herold, Stephanie1 (AUTHOR) stephanie.herold@unimedizin-mainz.de, Schmidt, Christian2 (AUTHOR), Visco, Carlo3 (AUTHOR), Tilch, Marie-Kristin1 (AUTHOR), Ohler, Anke1 (AUTHOR), Unterhalt, Michael2 (AUTHOR), Hoster, Eva4 (AUTHOR), Hoenig, Elisabeth5 (AUTHOR), Singer, Susanne6 (AUTHOR), Tucci, Alessandra7 (AUTHOR), Pott, Christiane8 (AUTHOR), Ladetto, Marco9 (AUTHOR), Hess, Georg1 (AUTHOR), Dreyling, Martin2 (AUTHOR)
Source: BMC Cancer. 8/25/2025, Vol. 25 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 187534678
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Herold%2C+Stephanie%22">Herold, Stephanie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> stephanie.herold@unimedizin-mainz.de</i><br /><searchLink fieldCode="AR" term="%22Schmidt%2C+Christian%22">Schmidt, Christian</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Visco%2C+Carlo%22">Visco, Carlo</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tilch%2C+Marie-Kristin%22">Tilch, Marie-Kristin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ohler%2C+Anke%22">Ohler, Anke</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Unterhalt%2C+Michael%22">Unterhalt, Michael</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hoster%2C+Eva%22">Hoster, Eva</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hoenig%2C+Elisabeth%22">Hoenig, Elisabeth</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Singer%2C+Susanne%22">Singer, Susanne</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tucci%2C+Alessandra%22">Tucci, Alessandra</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pott%2C+Christiane%22">Pott, Christiane</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ladetto%2C+Marco%22">Ladetto, Marco</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hess%2C+Georg%22">Hess, Georg</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dreyling%2C+Martin%22">Dreyling, Martin</searchLink><relatesTo>2</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 8/25/2025, Vol. 25 Issue 1, p1-9. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=187534678
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-025-14803-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 1
    Titles:
      – TitleFull: The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Herold, Stephanie
      – PersonEntity:
          Name:
            NameFull: Schmidt, Christian
      – PersonEntity:
          Name:
            NameFull: Visco, Carlo
      – PersonEntity:
          Name:
            NameFull: Tilch, Marie-Kristin
      – PersonEntity:
          Name:
            NameFull: Ohler, Anke
      – PersonEntity:
          Name:
            NameFull: Unterhalt, Michael
      – PersonEntity:
          Name:
            NameFull: Hoster, Eva
      – PersonEntity:
          Name:
            NameFull: Hoenig, Elisabeth
      – PersonEntity:
          Name:
            NameFull: Singer, Susanne
      – PersonEntity:
          Name:
            NameFull: Tucci, Alessandra
      – PersonEntity:
          Name:
            NameFull: Pott, Christiane
      – PersonEntity:
          Name:
            NameFull: Ladetto, Marco
      – PersonEntity:
          Name:
            NameFull: Hess, Georg
      – PersonEntity:
          Name:
            NameFull: Dreyling, Martin
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 08
              Text: 8/25/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 14712407
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC Cancer
              Type: main
ResultId 1